Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FUJIFILM Irvine Scientific Leverages Discovery Research Biz | Contract Pharma

What are you searching for?

Sign in
Breaking News

FUJIFILM Irvine Scientific Leverages Discovery Research Biz

Aims to enable faster, efficient delivery of Cellular Dynamics iPSC-derived products for drug discovery and development

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

FUJIFILM Cellular Dynamics, Inc. (FCDI), a developer and manufacturer of human induced pluripotent stem cells (iPSCs) and differentiated tissue-specific iPSCs, and FUJIFILM Irvine Scientific, Inc., a provider of cell culture media, will sell iCell products under the FUJIFILM “Discovery Research” organization (part of FUJIFILM Irvine Scientific).
 
“At Fujifilm we are dedicated to helping customers accelerate their innovation and discoveries to advance research that can result in drug discovery and development,” said Takeshi Yamamoto, CEO, FUJIFILM Cellular Dynamics, Inc. “By joining forces with FUJIFILM Irvine Scientific to bring our iCell products to customers, we can now leverage synergies and strengths to benefit our partners and ultimately, drive even greater progress in the field.”
 
FUJIFILM Irvine Scientific is a developer and manufacturer of cell culture media for biopharmaceuticals, cell and gene therapy, regenerative medicine and reproductive medicine.
 
While access to FUJIFILM Irvine Scientific’s worldwide distribution channels is the first step, the two Fujifilm Group companies will also work together on introducing new joint product kits in the future.
 
“Fujifilm’s expertise in the life sciences supports drug development from early phase research through to commercialization,” said Yutaka Yamaguchi, CEO, FUJIFILM Irvine Scientific. “Fujifilm Group’s resources allow us to tap our collective pool of knowledge and provide complete end-to-end solutions for our customers. Together, we can do more, faster and better.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics